Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$4.03 - $7.81 $222,750 - $431,682
55,273 Added 81.87%
122,784 $880,000
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $110,042 - $312,575
67,511 New
67,511 $306,000
Q1 2023

May 15, 2023

SELL
$3.74 - $7.46 $19,859 - $39,612
-5,310 Reduced 32.07%
11,250 $43,000
Q4 2022

Feb 14, 2023

BUY
$4.56 - $6.61 $75,513 - $109,461
16,560 New
16,560 $85,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $312M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Lighthouse Investment Partners, LLC Portfolio

Follow Lighthouse Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lighthouse Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lighthouse Investment Partners, LLC with notifications on news.